AstraZeneca To Buy US-based Icosavax In Around $1.1 Bln Deal

(RTTNews) - British drug major AstraZeneca Plc. (AZN.L, AZN) announced Tuesday that it has entered into a definitive agreement to acquire Icosavax, Inc. (ICVX), a US-based clinical-stage biopharmaceutical company, for a transaction value of around $1.1 billion. https://www.nasdaq.com/articles/astrazeneca-to-buy-us-based-icosavax-in-around-$1.1-bln-deal